124 related articles for article (PubMed ID: 6809030)
1. Cutaneous T-cell lymphoma: clinicopathological relationships, therapy and survival in ninety-two patients.
Hamminga L; Hermans J; Noordijk EM; Meijer CJ; Scheffer E; Van Vloten WA
Br J Dermatol; 1982 Aug; 107(2):145-55. PubMed ID: 6809030
[TBL] [Abstract][Full Text] [Related]
2. [Malignant lymphoma of the skin].
Nakajima H; Miyamoto H
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
4. Combined modality therapy for tumor stage mycosis fungoides: results of a 10-year follow-up.
Hallahan DE; Griem ML; Griem SF; Medenica M; Soltani K; Lorincz AL; Baron JM
J Clin Oncol; 1988 Jul; 6(7):1177-83. PubMed ID: 3392562
[TBL] [Abstract][Full Text] [Related]
5. Combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic alternatives in cutaneous T-cell lymphoma.
Holloway KB; Flowers FP; Ramos-Caro FA
J Am Acad Dermatol; 1992 Sep; 27(3):367-78. PubMed ID: 1383293
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma.
Vonderheid EC; Tan ET; Kantor AF; Shrager L; Micaily B; Van Scott EJ
J Am Acad Dermatol; 1989 Mar; 20(3):416-28. PubMed ID: 2537348
[TBL] [Abstract][Full Text] [Related]
8. [T-cell lymphoma of the skin--clinicopathological relationships, therapy and survival].
Nagatani T; Kin S; Baba N; Miyamoto H; Nakajima H
Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(5):579-91. PubMed ID: 2585773
[TBL] [Abstract][Full Text] [Related]
9. Systemic polychemotherapy in patients with mycosis fungoides and lymph node involvement: a follow-up study of 17 patients.
Sentis HJ; Willemze R; Van Vloten WA
Acta Derm Venereol; 1985; 65(2):179-83. PubMed ID: 2408428
[TBL] [Abstract][Full Text] [Related]
10. Combination of etoposide, idarubicin, cyclophosphamide, vincristine, prednisone and bleomycin (VICOP-B) in the treatment of advanced cutaneous T-cell lymphoma.
Fierro MT; Doveil GC; Quaglino P; Savoia P; Verrone A; Bernengo MG
Dermatology; 1997; 194(3):268-72. PubMed ID: 9187846
[TBL] [Abstract][Full Text] [Related]
11. Combined modality treatment of cutaneous T cell lymphoma: results of a 6-year follow-up.
Winkler CF; Sausville EA; Ihde DC; Fischmann AB; Schechter GP; Kumar PP; Nibhanupdi JR; Minna JD; Makuch RW; Eddy JL
J Clin Oncol; 1986 Jul; 4(7):1094-100. PubMed ID: 3088220
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
13. [Primary cutaneous lymphoma--mycosis fungoides].
Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N
Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic approaches in cutaneous lymphoma.
Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
[TBL] [Abstract][Full Text] [Related]
15. [Modern therapy of mycosis fungoides].
Roenigk HH
Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
[TBL] [Abstract][Full Text] [Related]
16. [Lymphomas of the skin].
Nagatani T; Baba N; Nakajima H
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1308-13. PubMed ID: 7688500
[TBL] [Abstract][Full Text] [Related]
17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
18. [Standard and experimental therapy of cutaneous T-cell lymphoma].
Beyeler M; Dummer R
Hautarzt; 2003 Dec; 54(12):1177-84. PubMed ID: 14634747
[TBL] [Abstract][Full Text] [Related]
19. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cutaneous T-cell lymphoma.
Zackheim HS
Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
